Harvard University Faculty of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Harvard University Faculty of Medicine sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials 2 currently recruiting 7 completed early-phase tilt top decile by trial count

Harvard University Faculty of Medicine: 9 sponsored US clinical trials, 2 recruiting.

Harvard University Faculty of Medicine sponsors 9 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 7 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Migraine, Classic, with 1 trials.

Top-decile sponsor footprint

Harvard University Faculty of Medicine ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

9 total, page 1 of 1

RECRUITING NA

Chronic Non-Specific Neck Pain Treated With Tai Chi and Chiropractic Care

NCT05726331
RECRUITING

Human Epilepsy Genetics--Neuronal Migration Disorders Study

NCT00041600
COMPLETED NA

Integrative Migraine Pain Alleviation Through Chiropractic Therapy

NCT03177616
COMPLETED NA

Tai Chi for Enhancing Motor and Cognitive Function in Parkinson's Disease

NCT02418780
COMPLETED Phase 2

Trial of High-Dose Rifampin in Patients With TB

NCT01408914
COMPLETED Phase 2

Tai Chi, Physiologic Complexity, and Healthy Aging

NCT01340365
COMPLETED NA

Harnessing Placebo Effects: Non-Deceptive Use of Placebo in Irritable Bowel Syndrome (IBS)

NCT01010191
COMPLETED NA

Comparing the Effect of Video-cases and Text-cases on Medical Students' Learning in Tutorial

NCT01286025
COMPLETED NA

Spaced Education to Optimize Prostate Cancer Screening

NCT01168323

Phase Distribution

PhaseTrial count
Phase 2 2

Therapeutic Areas

Migraine, Classic 1
Cognition Disorder 1
Neuronal Migration Disorder 1
Brain Malformation 1
Migraine Without Aura 1
Migraine With Aura 1
Neck Pain 1
Irritable Bowel Syndrome 1
Migraine Disorders 1
Migraine 1

What is open in the Harvard University Faculty of Medicine pipeline

2 recruiting of 9 indexed (22% open); 7 completed (78%).

Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).

Top condition: Migraine, Classic (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Harvard University Faculty of Medicine: open-pipeline peers nationwide

Peers matched on 9 registered trials and 22% open enrollment, not the therapeutic-area sidebar.

Harvard University Faculty of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 8101214161820 0%10%20%30%40%50% Total trials Recruiting share Harvard University Faculty of Medicine4D Molecular Therapeutics9 Meters BiopharmaAadi BioscienceAblynx, a Sanofi companyALX OncologyBiosense WebsterEnglewood Hospital and Medical CenterEnsysce Biosciences
Harvard University Faculty of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Harvard University Faculty of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 trials (± recruiting share)

Sponsors near 22% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Harvard University Faculty of Medicine page

9 registered trials is a research-attention snapshot, not an endorsement of Harvard University Faculty of Medicine or any single study.

  • 2 of Harvard University Faculty of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Migraine, Classic is the condition Harvard University Faculty of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Migraine, Classic trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Harvard University Faculty of Medicine pipeline card: 9 registered trials from official public datasets.Report a data error.